In FGF-2+ tumors, tumor microvessels were highly perfused with 2000-kD Rhodamine-labeled lysinated dextran (Fig. 2a and b), which were significantly compromised in the Fgf2-shRNA-transfected tumors (Fig. 2c and d). This evidence concerns the gene FGF2 and neoplasm.